Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ATNM | Actinium Pharmaceuticals, Inc. | DAVE KAUSHIK J | CEO and Interim CFO | Apr 14, 2016 | Buy | $2.02 | 10,000 | 20,180 | 88,500 | Apr 18, 2016, 05:27 PM | |
ATNM | Actinium Pharmaceuticals, Inc. | DAVE KAUSHIK J | President, CEO and Interim CFO | May 07, 2015 | Option Exercise | $2.45 | 156,084 | 382,406 | 85,583 | May 22, 2015, 05:08 PM | |
ATRS | ANTARES PHARMA, INC. | DAVE KAUSHIK J | Executive Vice President | Jun 03, 2013 | Sale | $2.24 | 96,000 | 215,107 | 313,028 | Jun 05, 2013, 04:40 PM | |
ATRS | ANTARES PHARMA, INC. | DAVE KAUSHIK J | Executive Vice President | May 06, 2013 | Sale | $2.25 | 24,000 | 53,881 | 218,106 | May 08, 2013, 05:53 PM |